Back to Results
First PageMeta Content
Diols / Expectorants / Guaifenesin / Uric acid / Food and Drug Administration / New Drug Application / Pharmaceutical sciences / Pharmacology / Medicine


November 12,2002 VIA FEDERAL
Add to Reading List

Document Date: 2002-12-09 11:22:27

Open Document

File Size: 1,46 MB

Share Result on Facebook

Company

Kirkpatrick & Lockhart LLP / Maryland 20852 CITIZEN / Perot / Adams Laboratories Inc . / McDermott / Topeka & Santa Fe Railway Co. / Leach Corp. / Kaplan and Becker LLP / Olsson / Rockville / Kleinfeld / Will & Emery / /

Country

United States / /

Event

FDA Phase / Product Issues / Product Recall / /

IndustryTerm

individual products / prescribed products / pharmaceutical clients / pharmaceutical industry / guaifenesin products / prescription drug products / exceptive drug products / similarly-situated exceptive drug products / levothyroxine products / solicited applications / drug marketers / ith guaifenesin products / unapproved products / confirmed manufacturers / violative products / release guaifenesin drug products / prescription guaifenesin products / particular exceptive drug products / chemical entity / extended release guaifenesin products / affected drug products / ingle ingredient guaifenesin products / pharmaceutical products / unapproved drug products / law firms / release guaifenesin products / drug products / unapproved levothyroxine products / extended-release guaifenesin products / /

Organization

National Black Media Coalition / Supreme Court / Sierra Club / FDA’s office of Compliance / Congress / NDA / U.S. Food and Drug Administration / US Federal Reserve / F.C.C. / /

Position

private actor / Commissioner / representative / c e o / /

Product

Mucinex / market / digox / levothyroxine sodium / digoxin / DES1-II / MucinexB (guaifenesin) extended release / new drug / /

SocialTag